DermWire TV

49-64 of 163

New Analysis of Benzene Contamination in BPO Products
New Analysis of Benzene Contamination in BPO Products
DermWire TV
New Analysis of Benzene Contamination in BPO Products
DermWire TV Extra: 3-Year Clinical Data on Lebrikizumab
DermWire TV Extra: 3-Year Clinical Data on Lebrikizumab
DermWire TV
DermWire TV Extra: 3-Year Clinical Data on Lebrikizumab
Melinda Gooderham, MSc, MD, FRCPC
Melinda Gooderham, MSc, MD, FRCPC
FDA Approves Eli Lilly’s AD Drug Ebglyss (Lebrikizumab)
FDA Approves Eli Lilly’s AD Drug Ebglyss (Lebrikizumab)
DermWire TV
FDA Approves Eli Lilly’s AD Drug Ebglyss (Lebrikizumab)
NIH Analysis Examines Association Between AD and Comorbidities
NIH Analysis Examines Association Between AD and Comorbidities
DermWire TV
NIH Analysis Examines Association Between AD and Comorbidities
Study Examines Association Between Childhood BMI and Risk of Developing IMSDs
Study Examines Association Between Childhood BMI and Risk of Developing IMSDs
DermWire TV
Study Examines Association Between Childhood BMI and Risk of Developing IMSDs
DermWire TV Extra: SDPA President Amber Blair, PA-C, Previews Her New Column
DermWire TV Extra: SDPA President Amber Blair, PA-C, Previews Her New Column
DermWire TV
DermWire TV Extra: SDPA President Amber Blair, PA-C, Previews Her New Column
Amber Blair, PA-C
Amber Blair, PA-C
FDA Approves New Drug for Prurigo Nodularis; Long-Term Use of Dupilumab Examined
FDA Approves New Drug for Prurigo Nodularis; Long-Term Use of Dupilumab Examined
DermWire TV
FDA Approves New Drug for Prurigo Nodularis; Long-Term Use of Dupilumab Examined
DermWire TV Extra: How ILDS Helps Dermatology Go Global
DermWire TV Extra: How ILDS Helps Dermatology Go Global
DermWire TV
DermWire TV Extra: How ILDS Helps Dermatology Go Global
Neal Bhatia, MD; Henry Lim, MD
Neal Bhatia, MD; Henry Lim, MD
Dermatology and CTCL: Recommendations
Dermatology and CTCL: Recommendations
DermWire TV
Dermatology and CTCL: Recommendations
Larisa J. Geskin, MD
Larisa J. Geskin, MD
New Clinical Guidelines for Nonmelanoma Skin Cancer Treatment; Arctics Biotherapeutics Seeks New FDA Approval for ZORYVE Foam
New Clinical Guidelines for Nonmelanoma Skin Cancer Treatment; Arctics Biotherapeutics Seeks New FDA Approval for ZORYVE Foam
DermWire TV
New Clinical Guidelines for Nonmelanoma Skin Cancer Treatment; Arctics Biotherapeutics Seeks New FDA Approval for ZORYVE Foam
FDA Approves New AD Treatment; Study Examines Omega-3 Fatty Acids in Managing Acne
FDA Approves New AD Treatment; Study Examines Omega-3 Fatty Acids in Managing Acne
DermWire TV
FDA Approves New AD Treatment; Study Examines Omega-3 Fatty Acids in Managing Acne
FDA Approves Axillary Hyperhidrosis Treatment; Study Examines Biologic Outcomes in Psoriasis
FDA Approves Axillary Hyperhidrosis Treatment; Study Examines Biologic Outcomes in Psoriasis
DermWire TV
FDA Approves Axillary Hyperhidrosis Treatment; Study Examines Biologic Outcomes in Psoriasis
DermWireTV Extra: Dr. Bhatia and Dr. Schlesinger Discuss Collaboration With Oncologists
DermWireTV Extra: Dr. Bhatia and Dr. Schlesinger Discuss Collaboration With Oncologists
Skin Cancer & Photoprotection
DermWireTV Extra: Dr. Bhatia and Dr. Schlesinger Discuss Collaboration With Oncologists
Neal Bhatia, MD, FAAD; Todd E. Schlesinger, MD
Neal Bhatia, MD, FAAD; Todd E. Schlesinger, MD
DermWireTV Extra: Dr. Alexandra Golant on Atopic Dermatitis Awareness
DermWireTV Extra: Dr. Alexandra Golant on Atopic Dermatitis Awareness
Atopic Dermatitis
DermWireTV Extra: Dr. Alexandra Golant on Atopic Dermatitis Awareness
Alexandra Golant, MD, FAAD
Alexandra Golant, MD, FAAD
DermWireTV: Diagnosing Melanoma Using Deep-Learning Model; New Adbry Approval
DermWireTV: Diagnosing Melanoma Using Deep-Learning Model; New Adbry Approval
DermWire TV
DermWireTV: Diagnosing Melanoma Using Deep-Learning Model; New Adbry Approval
DermwireTV: Rinvoq Approved for Pediatric Psoriatic Arthritis; J&J Acquires Novel AD Candidate
DermwireTV: Rinvoq Approved for Pediatric Psoriatic Arthritis; J&J Acquires Novel AD Candidate
DermWire TV
DermwireTV: Rinvoq Approved for Pediatric Psoriatic Arthritis; J&J Acquires Novel AD Candidate

4/9